Back to top
more

Avanos Medical (AVNS)

(Real Time Quote from BATS)

$23.85 USD

23.85
71,731

+0.31 (1.32%)

Updated Sep 13, 2024 03:28 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Baxter (BAX) to Report Q2 Earnings: What's in the Cards?

by Zacks Equity Research

Baxter's (BAX) second-quarter results are likely to reflect growth in its Acute Therapies business.

PerkinElmer (PKI) to Post Q2 Earnings: What's in the Cards?

by Zacks Equity Research

PerkinElmer's (PKI) second-quarter results are likely to reflect strong performance at Diagnostics segment.

Stryker (SYK) to Report Q2 Earnings: What's in the Cards?

by Zacks Equity Research

Stryker's (SYK) second-quarter results are likely to reflect strong segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine.

What's in Store for Intuitive Surgical's (ISRG) Q2 Earnings?

by Zacks Equity Research

Intuitive Surgical's (ISRG) second-quarter results are likely to reflect solid performance at Instruments & Accessories segment.

Here's Why You Should Retain Avanos (AVNS) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.

Here's Why You Should Hold on to Avanos (AVNS) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Avanos (AVNS), owing to its strong product line and focus on its R&D.

Avanos Medical (AVNS) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

Avanos Medical (AVNS) continues to gain from its core Chronic Care segment in the first quarter.

Avanos Medical (AVNS) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Avanos Medical (AVNS) delivered earnings and revenue surprises of 27.78% and 2.30%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Avanos Medical (AVNS) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Avanos Medical (AVNS) Down 1% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Retain Avanos Medical (AVNS) Stock Now

by Zacks Equity Research

Investor confidence is high in Avanos Medical (AVNS) stock, courtesy of its solid prospects.

Avanos Medical (AVNS) Q4 Earnings and Revenues Top Estimates

by Zacks Equity Research

Avanos Medical (AVNS) continues to gain from its core Chronic Care segment in the fourth quarter.

Avanos Medical (AVNS) Tops Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Avanos Medical (AVNS) delivered earnings and revenue surprises of 27.27% and 0.67%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Why You Should Retain Avanos Medical (AVNS) Stock for Now

by Zacks Equity Research

Investor confidence is high on Avanos Medical (AVNS), courtesy of solid prospects.

    Why Is Avanos Medical (AVNS) Up 3.7% Since Last Earnings Report?

    by Zacks Equity Research

    Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    Avanos Medical (AVNS) Q3 Earnings and Revenues Top Estimates

    by Zacks Equity Research

    Avanos Medical (AVNS) continued to gain from core Chronic Care segment in the third quarter.

    Avanos Medical (AVNS) Q3 Earnings and Revenues Beat Estimates

    by Zacks Equity Research

    Avanos Medical (AVNS) delivered earnings and revenue surprises of 50.00% and 11.94%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

    Here's Why You Should Retain Avanos Medical Stock for Now

    by Zacks Equity Research

    Investor confidence is high on Avanos Medical (AVNS), thanks to solid prospects.

    Why Is Avanos Medical (AVNS) Up 5.7% Since Last Earnings Report?

    by Zacks Equity Research

    Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    Avanos Medical (AVNS) Q2 Earnings and Revenues Top Estimates

    by Zacks Equity Research

    Avanos Medical's (AVNS) second-quarter results benefit from contribution from Chronic Care segment.

    Avanos Medical (AVNS) Q2 Earnings and Revenues Surpass Estimates

    by Zacks Equity Research

    Avanos Medical (AVNS) delivered earnings and revenue surprises of 262.50% and 10.19%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

    Avanos Medical (AVNS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

    by Zacks Equity Research

    Avanos Medical (AVNS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Here's Why You Should Retain Avanos Medical Stock for Now

    by Zacks Equity Research

    Investor confidence is high on Avanos Medical (AVNS), thanks to solid prospects.

    Avanos Medical (AVNS) Up 0.1% Since Last Earnings Report: Can It Continue?

    by Zacks Equity Research

    Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    Here's Why You Should Retain Avanos Medical Stock for Now

    by Zacks Equity Research

    Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, stiff competition remains a concern.